Press release by the Company titled 'Hester acquires technology from ICAR - NIHSAD to develop a Low Pathogenic Avian Influenza (H9N2 strain) Inactivated Vaccine for poultry'

pdf

Hester Biosciences Ltd.

19 Dec 2022

1721.00

-1.19%

Corp. Note

HESTER BIOSCIENCES LTD. - 524669 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Loss of Share certificates intimation

pdf

Hester Biosciences Ltd.

10 Dec 2022

1721.00

-1.19%

Corp. Note

HESTER BIOSCIENCES LTD. - 524669 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Loss of share certificate

pdf

Hester Biosciences Ltd.

16 Nov 2022

1721.00

-1.19%

Company Update

HESTER BIOSCIENCES LTD. - 524669 - Disclosure Of Related Party Transactions For The Half Year Ended …

BSE India

Disclosure of Related Party Transactions for the half year ended 30 September 2022

pdf

Hester Biosciences Ltd.

07 Nov 2022

1721.00

-1.19%

Company Update

HESTER BIOSCIENCES LTD. - 524669 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit a copy of the published extract of consolidated unaudited financial results for the quarter and half year ended 30 September 2022 along with information on standalone financial results. The same was published on Saturday, 5 November 2022 in the Ahmedabad edition of Financial Express (English) and Financial Express (Gujarati). This is for your information and records

pdf

Hester Biosciences Ltd.

07 Nov 2022

1721.00

-1.19%

Earnings Call

HESTER BIOSCIENCES LTD. - 524669 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to Regulations 30 and 46(2)(oa) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the transcript of the earnings conference call held by the management of the Company with investors on Friday, 4 November 2022 at 2:00 p.m. (IST) to discuss the unaudited financial results for the quarter and half year ended 30 September 2022. This is for your information and records.

pdf

Hester Biosciences Ltd.

04 Nov 2022

1721.00

-1.19%

Earnings Call

HESTER BIOSCIENCES LTD. - 524669 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to Regulations 30 and 46(2)(oa) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the audio recording of the Company's earnings conference call on the unaudited financial results for the quarter and half year ended 30 September 2022 is available on the Company's website: www.hester.in. The link to access the said audio recording is: https://www.hester.in/information/earnings-call This is for your information and records.

pdf

Hester Biosciences Ltd.

04 Nov 2022

1721.00

-1.19%

to see Rapid results content

Is Hester Biosciences Ltd. worth buying?

81 Votes:

Buy 80.25%

Sell 11.11%

Hold 8.64%